Latest Regenerative October 14, 2025 News

The Phase 2 study showed good results for placenta-derived cell therapy for diabetic foot ulcers complicated by PAD.
Keensight Capital’s investment aims to accelerate Isto Biologics’ growth and international expansion in the orthobiologics sector.

Stay updated on Regenerative Medicine